ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
US FDA approves Viltepso injection for treatment of Duchenne muscular dystrophy mutation
August 14, 2020The US Food and Drug Administration granted accelerated approval to Viltepso (viltolarsen) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
Pharma Sources Insight January 2025
